Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - DoveBid: Biopharma Auctions  
 Home
 About BioEndeavor
 Become a Member
  Join Our Network
  Research Fellows
 Training
  Upcoming Workshops
  Future Workshops
 Projects
  BioConvergence Innovation
  Genomics
  System Biology
  Synthetic Biology
  Nanotechnology
  Environment/BioEnergy
  IAD
  Capacity Development
 Papers
 Company Case Studies
 BioInnovation News
  The BioCommons
  Emerging Market News
 Events
 Open Innovation Directory
 Biopharma Capacity Development-Emerging and BoP Markets (NEW!)
 

Click here to subscribe to the BioEndeavor Newsletter

 Featured Event   Show all: Featured Event

 Partner Innovation Blogs   Show all: Partner Innovation Blogs

The 2014 Skoll World Forum


The Skoll World Forum is a programme of the Skoll Foundation and is co-produced with the Skoll Centre for Social Entrepreneurship at the Saïd Business School, Oxford University.
Read More...

Journal coverIncreasingly, open-source–based alliances seek to provide broad access to data, research-based tools, preclinical samples and downstream compounds. The challenge is how to create value from open-source biopharmaceutical innovation. This value creation may occur via transparency and usage of data across the biopharmaceutical value chain as stakeholders move dynamically between open source and open innovation.

It is the author’s opinion that the assessment of when and how value creation will occur, through open-source biopharmaceutical innovation, is paramount. The key is to determine the metrics of value creation and the necessary technological, educational and legal frameworks to support the downstream outcomes of now big data-based open-source initiatives. The continued focus on the early-stage value creation is not advisable. Instead, it would be more advisable to adopt an approach where stakeholders transform open-source initiatives into open-source discovery, crowdsourcing and open product development partnerships on the same platform.
Read More:
http://informahealthcare.com/doi/abs/10.1517/17460441.2014.905539?af=R

AstraZeneca unit debuts new open innovation platform for partnering programs
March 25 2014
The Pharma Letter

Anglo-Swedish drug major AstraZeneca’s IMED Biotech unit has launched a dedicated web site to support an increasing range of open innovation programs and to better facilitate research collaborations with academia, industry, non-governmental organizations (NGOs) and governments.

Global Innovation Index 2013

INSEAD-WIPO-Cornell University rank 142 countries on their innovation capabilities. Sixth annual index reshuffles the top ten and shows gap widening between rich and poor countries.
Read More...

University Partnerships in the Era of University Innovation Merchants– a Practical Guide for Companies
February 2014

Assess the opportunities and challenges of engaging in open innovation with universities.
Read More...


Continue Reading More Innovation News and Blogs...


 Calls for Papers, Proposals, Experts   Show all: Calls for Papers, Proposals, Experts

 What's New on BioEndeavor   Show all: What's New on BioEndeavor

 

 The National Academies Press   Show all: The National Academies Press

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS:  Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences

 

 

 

 

 

 



 

The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS:
Challenges and Opportunities: Summary of a Joint Workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences (2014)
Forthcoming...


 Follow BioEndeavor on LinkedIn   Show all: Follow BioEndeavor on LinkedIn

LinkedIn Group
Join the discussion on open source drug discovery and human capital development through open innovation at the bottom of the pyramid

Follow our profile on Linkedin to keep up to date about upcoming training, research and consulting services.



© 2010-2014 BioEndeavor.Net   
Privacy and Security Statement   Disclaimer Adding Directory Profiles